Value of p63 and Cytokeratin 5/6 as Immunohistochemical Markers for the Differential Diagnosis of Poorly Differentiated and Undifferentiated Carcinomas
Top Cited Papers
Open Access
- 1 December 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 116 (6) , 823-830
- https://doi.org/10.1309/21tw-2ndg-jrk4-pfjx
Abstract
To facilitate the differential diagnosis of poorly differentiated metastatic carcinomas of unknown primary site, we evaluated p63 and cytokeratin (CKKeywords
This publication has 25 references indexed in Scilit:
- p63 Is a Prostate Basal Cell Marker and Is Required for Prostate DevelopmentThe American Journal of Pathology, 2000
- Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesLaboratory Investigation, 2000
- High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?Oncogene, 2000
- Uroplakin III Is a Highly Specific and Moderately Sensitive Immunohistochemical Marker for Primary and Metastatic Urothelial CarcinomasAmerican Journal of Clinical Pathology, 2000
- Association of p63 with Proliferative Potential in Normal and Neoplastic Human KeratinocytesJournal of Investigative Dermatology, 1999
- Metastasen bei unbekanntem Prim rtumorDer Onkologe, 1997
- Blocking of Endogenous Avidin-Binding Activity in ImmunohistochemistryApplied Immunohistochemistry & Molecular Morphology, 1997
- Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissuesThe Journal of Pathology, 1994
- Large Cell Carcinoma of the LungChest, 1986
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982